This inventor holds 1 USPTO granted patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations by Wei-Jian Pan in Treating Hypophosphatasia
Introduction
Wei-Jian Pan is a notable inventor based in Boston, MA, who has made significant contributions to the field of medicine. He is particularly recognized for his work on methods for treating hypophosphatasia (HPP), a rare genetic disorder that affects bone mineralization. His innovative approach aims to improve the quality of life for patients suffering from this condition.
Latest Patents
Wei-Jian Pan holds a patent for "Methods for treating hypophosphatasia (HPP) in adults and adolescents." This patent outlines methods for treating patients exhibiting decreased pyrophosphate (PPi) or pyridoxal 5'-phosphate (PLP) concentrations. The treatment involves administering a soluble alkaline phosphatase (sALP) to patients, which can help alleviate physical impairments and improve walking ability.
Career Highlights
Wei-Jian Pan is currently employed at Alexion Pharmaceuticals, Inc., where he continues to advance research in the treatment of rare diseases. His work has garnered attention for its potential to change the lives of individuals affected by HPP. With a focus on innovative solutions, he has dedicated his career to improving patient outcomes.
Collaborations
Throughout his career, Wei-Jian Pan has collaborated with esteemed colleagues, including Scott Edward Moseley and Andrew Evan Denker. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Wei-Jian Pan's contributions to the treatment of hypophosphatasia highlight the importance of innovation in medicine. His patent and ongoing work at Alexion Pharmaceuticals, Inc. demonstrate his commitment to improving the lives of patients with rare diseases. His efforts are a testament to the impact that dedicated inventors can have in the field of healthcare.